Your town. Your news. Your take.

Local News: Los Angeles, CA 

 | 

Sign Up

 | 

Sign In

 
Advertisment
Amgen

Jul 3, 2008

Amgen's Experimental Drug Motesanib May Slow Thyroid Cancer, Study Finds

Amgen Inc. 's experimental cancer drug motesanib delayed or reversed growth of thyroid tumors in a small study of patients with advanced malignancies.

Leave a Comment

Comments

Type in your comments to post to the forum
Name
(appears on your post)
Comments
Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Amgen Discussions
Topic Updated Last By Comments
Amgen's help now problem for some Aug '08 LadyIsREAL 2
Biz Buzz: Business briefs for Thursday, July 31... Jul '08 Madeline McCann 1
Is Amgen Hiring? Jul '08 The mex 2
EU Panel Backs Curbing Use Of Anemia Drugs In C... Jun '08 gdpawel 1
Simi Valley man gets two years for embezzling f... May '08 love animals 1
FDA panel gives surprise OK to Amgen and J&J (from Mar '08) Mar '08 Treat Cancer 3
Limits proposed for anemia drugs (from Mar '08) Mar '08 Dr Bendover 4